Selected research
Market Structure
Global Isosorbide Mononitrate Sustained-release Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Isosorbide Mononitrate Sustained-release Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Isosorbide Mononitrate Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Isosorbide Mononitrate Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Isosorbide Mononitrate Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Isosorbide Mononitrate Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Isosorbide Mononitrate Sustained-release Tablet include Lotus Pharmaceuticals, Mayo Clinic, Recipeharm, Hefei Cosource Pharmacetical, Keyuan Pharmaceutical, Lepu Pharmaceuticals and Lukang Jituan Saite Yaoye, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Isosorbide Mononitrate Sustained-release Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Isosorbide Mononitrate Sustained-release Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Isosorbide Mononitrate Sustained-release Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Isosorbide Mononitrate Sustained-release Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.
Isosorbide Mononitrate Sustained-release Tablet Segment by Company
Lotus Pharmaceuticals
Mayo Clinic
Recipeharm
Hefei Cosource Pharmacetical
Keyuan Pharmaceutical
Lepu Pharmaceuticals
Lukang Jituan Saite Yaoye
Isosorbide Mononitrate Sustained-release Tablet Segment by Type
40mg
50mg
Other
Isosorbide Mononitrate Sustained-release Tablet Segment by Application
Hospital
Clinic
Other
Isosorbide Mononitrate Sustained-release Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isosorbide Mononitrate Sustained-release Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Isosorbide Mononitrate Sustained-release Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isosorbide Mononitrate Sustained-release Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Isosorbide Mononitrate Sustained-release Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Isosorbide Mononitrate Sustained-release Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Isosorbide Mononitrate Sustained-release Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Isosorbide Mononitrate Sustained-release Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 40mg
- 50mg
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Lotus Pharmaceuticals
- Mayo Clinic
- Recipeharm
- Hefei Cosource Pharmacetical
- Keyuan Pharmaceutical
- Lepu Pharmaceuticals
- Lukang Jituan Saite Yaoye
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Isosorbide Mononitrate Sustained-release Tablet Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Isosorbide Mononitrate Sustained-release Tablet Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Isosorbide Mononitrate Sustained-release Tablet Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Isosorbide Mononitrate Sustained-release Tablet Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Isosorbide Mononitrate Sustained-release Tablet Market Dynamics
- 2.1 Isosorbide Mononitrate Sustained-release Tablet Industry Trends
- 2.2 Isosorbide Mononitrate Sustained-release Tablet Industry Drivers
- 2.3 Isosorbide Mononitrate Sustained-release Tablet Industry Opportunities and Challenges
- 2.4 Isosorbide Mononitrate Sustained-release Tablet Industry Restraints
3 Isosorbide Mononitrate Sustained-release Tablet Market by Manufacturers
- 3.1 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Manufacturers (2021-2026)
- 3.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Manufacturers (2021-2026)
- 3.3 Global Isosorbide Mononitrate Sustained-release Tablet Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Isosorbide Mononitrate Sustained-release Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Isosorbide Mononitrate Sustained-release Tablet Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Isosorbide Mononitrate Sustained-release Tablet Manufacturers, Product Type & Application
- 3.7 Global Isosorbide Mononitrate Sustained-release Tablet Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Isosorbide Mononitrate Sustained-release Tablet Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Isosorbide Mononitrate Sustained-release Tablet Players Market Share by Revenue in 2025
- 3.8.3 2025 Isosorbide Mononitrate Sustained-release Tablet Tier 1, Tier 2, and Tier 3
4 Isosorbide Mononitrate Sustained-release Tablet Market by Type
- 4.1 Isosorbide Mononitrate Sustained-release Tablet Type Introduction
- 4.1.1 40mg
- 4.1.2 50mg
- 4.1.3 Other
- 4.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Type
- 4.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Type (2021-2032)
- 4.2.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share by Type (2021-2032)
- 4.3 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Type
- 4.3.1 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Type (2021-2032)
- 4.3.3 Global Isosorbide Mononitrate Sustained-release Tablet Revenue Market Share by Type (2021-2032)
5 Isosorbide Mononitrate Sustained-release Tablet Market by Application
- 5.1 Isosorbide Mononitrate Sustained-release Tablet Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Application
- 5.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Application (2021-2032)
- 5.2.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share by Application (2021-2032)
- 5.3 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Application
- 5.3.1 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Application (2021-2032)
- 5.3.3 Global Isosorbide Mononitrate Sustained-release Tablet Revenue Market Share by Application (2021-2032)
6 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Region
- 6.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Region (2021-2032)
- 6.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Region (2021-2026)
- 6.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Isosorbide Mononitrate Sustained-release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Region
- 7.1 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Region
- 7.1.1 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Region (2021-2026)
- 7.1.3 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Region (2027-2032)
- 7.1.4 Global Isosorbide Mononitrate Sustained-release Tablet Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Isosorbide Mononitrate Sustained-release Tablet Revenue (2021-2032)
- 7.2.2 North America Isosorbide Mononitrate Sustained-release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Isosorbide Mononitrate Sustained-release Tablet Revenue (2021-2032)
- 7.3.2 Europe Isosorbide Mononitrate Sustained-release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Revenue (2021-2032)
- 7.4.2 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Isosorbide Mononitrate Sustained-release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Lotus Pharmaceuticals
- 8.1.1 Lotus Pharmaceuticals Company Information
- 8.1.2 Lotus Pharmaceuticals Business Overview
- 8.1.3 Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 8.1.5 Lotus Pharmaceuticals Recent Developments
- 8.2 Mayo Clinic
- 8.2.1 Mayo Clinic Company Information
- 8.2.2 Mayo Clinic Business Overview
- 8.2.3 Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 8.2.5 Mayo Clinic Recent Developments
- 8.3 Recipeharm
- 8.3.1 Recipeharm Company Information
- 8.3.2 Recipeharm Business Overview
- 8.3.3 Recipeharm Isosorbide Mononitrate Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Recipeharm Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 8.3.5 Recipeharm Recent Developments
- 8.4 Hefei Cosource Pharmacetical
- 8.4.1 Hefei Cosource Pharmacetical Company Information
- 8.4.2 Hefei Cosource Pharmacetical Business Overview
- 8.4.3 Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 8.4.5 Hefei Cosource Pharmacetical Recent Developments
- 8.5 Keyuan Pharmaceutical
- 8.5.1 Keyuan Pharmaceutical Company Information
- 8.5.2 Keyuan Pharmaceutical Business Overview
- 8.5.3 Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 8.5.5 Keyuan Pharmaceutical Recent Developments
- 8.6 Lepu Pharmaceuticals
- 8.6.1 Lepu Pharmaceuticals Company Information
- 8.6.2 Lepu Pharmaceuticals Business Overview
- 8.6.3 Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 8.6.5 Lepu Pharmaceuticals Recent Developments
- 8.7 Lukang Jituan Saite Yaoye
- 8.7.1 Lukang Jituan Saite Yaoye Company Information
- 8.7.2 Lukang Jituan Saite Yaoye Business Overview
- 8.7.3 Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
- 8.7.5 Lukang Jituan Saite Yaoye Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Isosorbide Mononitrate Sustained-release Tablet Value Chain Analysis
- 9.1.1 Isosorbide Mononitrate Sustained-release Tablet Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Isosorbide Mononitrate Sustained-release Tablet Production Mode & Process
- 9.2 Isosorbide Mononitrate Sustained-release Tablet Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Isosorbide Mononitrate Sustained-release Tablet Distributors
- 9.2.3 Isosorbide Mononitrate Sustained-release Tablet Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst